|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Obstructive Sleep Apnea | |||||
| Gastroesophageal Reflux | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Apnea | |||||
| Sleep Apnea Syndromes | |||||
| Sleep Apnea, Obstructive | |||||
| 3 | More general conditions related to this trial | ||||
| Deglutition Disorders | |||||
| Digestive System Diseases | |||||
| Dyssomnias | |||||
| Esophageal Diseases | |||||
| Esophageal Motility Disorders | |||||
| Gastrointestinal Diseases | |||||
| Nervous System Diseases | |||||
| Respiration Disorders | |||||
| Respiratory Tract Diseases | |||||
| Signs and Symptoms | |||||
| Signs and Symptoms, Respiratory | |||||
| Sleep Disorders | |||||
| Sleep Disorders, Intrinsic | |||||
| 4 | Interventions listed in this trial | ||||
| Lansoprazole | |||||
| 5 | More general drug interventions related to this trial | ||||
| Anti-Infective Agents | |||||
| Anti-Ulcer Agents | |||||
| Enzyme Inhibitors | |||||
| Gastrointestinal Agents | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Pharmacologic Actions | |||||
| Therapeutic Uses | |||||
| 6 | Sponsors listed in this trial | ||||
| MetroHealth Medical Center | |||||